Lung Cancer

Lung Cancer Treatment

Taussig Cancer Institute's Thoracic Oncology Program offers patients with thoracic malignancies leading-edge, multidisciplinary care. In consultation with patients, collaborative teams of surgical, medical, and radiation oncologists tailor treatment plans to the needs of each patient. An active clinical research program provides patients with additional treatment options.

The Department of Radiation Oncology actively participates in Cleveland Clinic in-house protocols and is a full member of the NRG Oncology research organization. The department is among the leading institutions nationally for accrual of patients to multiple NRG Oncology clinical trials.

Five-Year Overall Survival of Patients With All Stagesᵃ of Non-Small Cell Lung Cancer (N= 6917)

2008-2018

ᵃAJCC stage I-IV small cell lung cancer

ᵇHowlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER website, April 2016.

Five-Year Overall Survival of Patients With Non-Small Cell Lung Cancer by Stageᵃ (N = 6441)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage I (N = 2099) 1613 1159 815 563 344
Stage II (N = 697) 507 348 216 157 85
Stage III (N = 1318) 782 453 284 183 107
Stage IV (N = 2327) 850 394 187 106 57

ᵃAJCC stage I-IV non-small cell lung cancer

ᵇHowlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER website, April 2016

Overall Survival of Patients With Medically Inoperable Stage Iᵃ Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy (N = 1055)

2006-2016

ᵃAJCC stage I non-small cell lung cancer

ᵇThere is no reference value for year 4

ᶜZheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, Chang A, Lv F, Orringer M, Spring Kong FM. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):603-611

Local Control for Patients With Medically Inoperable Stage Iᵃ Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy (N = 1055)

2006-2016

CC = Cleveland Clinic

ᵃAJCC stage I non-small cell lung cancer

ᵇThere is no reference value for years 2 and 4

ᶜZheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, Chang A, Lv F, Orringer M, Spring Kong FM. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):603-611.

Five-Year Overall Survival of Patients With Stage IIIᵃ Non-Small Cell Lung Cancer Treated With Radiation (N= 827)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage IIIA (N = 549) 356 230 144 94 56
Stage IIIB (N = 278) 161 75 50 26 17

ᵃAJCC stage III non-small cell lung cancer

Five-Year Overall Survival of Patients With All Stages of Small Cell Lung Cancerᵃ (N= 798)

2008-2018

ᵃAmerican Joint Committee on Cancer (AJCC) stage I-IV non-small cell lung cancer

ᵇ Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER website, April 2016.

Five-Year Overall Survival of Patients With Early Stageᵃ Small Cell Lung Cancer (N = 309)

2008-2018

Number at Risk Year 1 Year 2 Year 3 Year 4 Year 5
Stage I (N = 72) 57 38 31 18 8
Stage II (N = 49) 31 19 12 9 5
Stage III (N = 188) 97 54 42 29 20

ᵃAJCC stage I-III small cell lung cancer